ADP-ribosylation, a multifaceted modification: Functions and mechanisms in aging and aging-related diseases

Wu Hao1, Zhao Jialong1, Yuan Jiuzhi1

  • 1College of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China.

PubMed

Insights

ADP-ribosylation, a protein modification, is crucial in aging and related diseases. Targeting this process may offer new therapeutic strategies for healthy aging and age-related conditions.

Area of Science:

  • Biochemistry and Molecular Biology
  • Gerontology
  • Cellular Biology

Background:

  • Aging is a complex biological process linked to numerous disorders, including cardiovascular diseases, stroke, neurodegenerative diseases, cancers, and lipid metabolism disorders.
  • ADP-ribosylation is a reversible post-translational modification that alters protein and nucleic acid structure and function.
  • Emerging evidence highlights the significant role of ADP-ribosylation and its associated enzymes in the aging process and age-related diseases.

Purpose of the Study:

  • To review ADP-ribosylation-associated proteins, including ADP-ribosyl transferases, ADP-ribosyl hydrolases, and ADP-ribose binding domains.
  • To summarize current knowledge on ADP-ribosylation's regulation in the pathogenesis and progression of major aging-related diseases, organism aging, and cellular senescence.
  • To explore underlying mechanisms and propose future research directions for ADP-ribosylation in aging and age-related diseases.

Main Methods:

  • Literature review and synthesis of existing research on ADP-ribosylation.
  • Analysis of ADP-ribosylation-associated proteins and their functions.
  • Examination of ADP-ribosylation's role in aging, cellular senescence, and age-related disease pathogenesis.

Main Results:

  • The review summarizes key ADP-ribosylation-associated proteins and their domains.
  • It details the regulatory roles of ADP-ribosylation in aging, senescence, and various age-related diseases.
  • Potential underlying molecular mechanisms linking ADP-ribosylation to aging are discussed.

Conclusions:

  • ADP-ribosylation is a critical molecular network implicated in aging and age-related diseases.
  • Targeting ADP-ribosylation pathways presents a promising therapeutic avenue for promoting healthy aging and treating age-related conditions.
  • Further research is needed to fully elucidate the bio-properties of ADP-ribosylation and its therapeutic potential.

Related Concept Videos

Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
48
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
12.2K
Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.5K
Protein Modifications in the RER01:26

Protein Modifications in the RER

Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.1K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
889